26 May 2013
Keywords: idec, non-hodgkin, lymphoma, antibody, clears, phase, iii
Article | 16 December 1996
IDEC and Genentech have reported that their antibody treatment for
non-Hodgkin's lymphoma, IDEC-C2B8, was found to be effective in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 December 1996
23 December 1996
24 May 2013
© 2013 thepharmaletter.com